Familial concordance of phenotype and microbial variation among siblings with CF

Pediatric Pulmonology

Volumn 38, Issue 4, 2004, Pages 292-297

  Picard, Elie ^a   Aviram, Micha ^b   Yahav, Yaakov ^c   Rivlin, Joseph ^d   Blau, Hanna ^d   Bentur, Lea ^e   Avital, Avraham ^f   Villa, Yael ^g   Schwartz, Shepard ^a   Kerem, Batsheva ^h   Kerem, Eitan ^a,f,i  

^a HEBREW UNIVERSITY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d CARMEL MEDICAL CENTER   (Israel)

^e RAMBAM MEDICAL CENTER   (Israel)

^f HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^g TEL AVIV UNIVERSITY   (Israel)

^h HEBREW UNIVERSITY OF JERUSALEM   (Israel)

ⁱ Dept of Pediatrics and CF Center ^*  (Israel)

Author keywords

Cross infection; Cystic fibrosis; Disease presentation; Genotypes; Modifier genes; Phenotypes; Siblings; Transmembrane conductance regulator

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATION; BODY HEIGHT; BODY WEIGHT; CHILD; CLINICAL FEATURE; CLINICAL OBSERVATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; FAMILY; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL SYMPTOM; GENE FUNCTION; GROWTH; HEALTH CENTER; HUMAN; ISRAEL; LUNG FUNCTION; MAJOR CLINICAL STUDY; MECONIUM ILEUS; MEDICAL RECORD; MUTATION; NUTRITIONAL STATUS; PANCREAS INSUFFICIENCY; PATIENT; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT DISEASE; SIBLING; SPUTUM; STAPHYLOCOCCUS AUREUS; SYMPTOM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENOTYPE; HUMANS; INFANT; ISRAEL; MUTATION; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SIBLINGS;

EID: 4544306219     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.20111     Document Type: Article

References (28)

1. www.genet.sickkids.on.ca/cftr/
2. Kerem E, Kerem B. Genotype-phenotype correlations in cystic fibrosis. Pediatr Pulmonol 1996;22:387-395.
3. Kristidis P, Bozon D, Corey M, Markiewicz D, Rommens J, Tsui LC, Durie P. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 1992;50:1178-1184.
4. Augarten A, Kerem B, Yahav Y, Noiman S, Rivlin J, Tal A, Blau H, Ben-Tur L, Szeinberg A, Kerem E. Mild cystic fibrosis and normal or borderline sweat test in patients with 3849+ 10kb C → T mutation. Lancet 1993;342:25-27.
5. Dean M, White MB, Amos J, Gerrard B, Stewart C, Khaw KT, Leppert M. Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients. Cell 1990;61:863-870.
6. Shoshani T, Augarten A, Gazit E, Bashan N, Yahav Y, Rivlin J, Tal A, Sereth H, Yaar L, Kerem E, Kerem B. Association of a nonsense mutation (W128X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel with presentation of severe disease. Am J Hum Genet 1992;50:222-228.
7. Kerem E, Corey M, Kerem B, Rommens J, Levison H, Tsui LC, Durie P. The relationship between genotype and phenotype in cystic fibrosis, analysis of the most common mutation ΔF508. N Engl J Med 1990;323:1517-1522.
8. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998;132:589-595.
9. Kerem B, Chiba-Falek O, Kerem E. Cystic fibrosis in Jews: frequency and mutation distribution. Genet Test 1997;1:35-39.
10. Lerer I, Laufer-Cahana A, Rivlin JR, Augarten A, Abeliovich D. A large deletion mutation in the CFTR gene (3120+ 1 Kb del 8.6 Kb): a founder mutation in the Palestinian Arabs. Mutation in brief no. 231. Hum Mutat 1999;13:337.
11. Kerem E, Corey M, Kerem B, Durie P, Tsui LC, Levison H. Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J Pediatr 1989;114:767-773.
12. Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 1993;325:1630-1634.
13. Gyomorey K, Rozmahel R, Bear CE. Amelioration of intestinal disease severity in cystic fibrosis mice is associated with improved chloride secretory capacity. Pediatr Res 2000;48:731-734.
14. Zielenski J, Corey M, Rozmahel R, Markiewicz D, Aznarez I, Casals T, Larriba S, Mercier B, Cutting GR, Kresbova A, Milan M, Langfelder-Schwind E, Marshall BC, Decelie-Germana J, Claustres M, Palacio A, Bal J, Nowaskowska A, Ferec C, Estivill X, Durie P, Tsui LC. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet 1999;22:128-129.
15. Farrell PM, Koscik RE. Sweat chloride concentrations in infants homozygous or heterozygous for DF508 cystic fibrosis. Pediatrics 1996;97:524-528.
16. Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, Hoffman G, Laessig RH, Splaingard ML. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screning Study Group. Pediatrics 2001;107:1-13.
17. Siret D, Branger B, Storni V, Bretaudeau G, Dagone M, Moisan-Petit V, David V, Picherot G, Rault G, Roussey M. Le depistage neonatal systematique ameliore-t-il le pronostic de la mucoviscidose? Etude comparative de deux cohortes en Bretagne et en Loire-Atlantique avec un recul de dix ans. Arch Pediatr 2000;7:1154-1162.
18. Corey M, Durie P, Moore D, Forstner G, Levison H. Familial concordance of pancreatic function in cystic fibrosis. J Pediatr 1989;115:274-277.
19. Orenstein DM, Boat TF, Stern RC, Tucker AS, Charnock EL, Matthews LW, Doershuk CF. The effect of early diagnosis and treatment in cystic fibrosis. A seven-year study of 16 sibling pairs. Am J Dis Child 1977;131:973-975.
20. Santis G, Osborne L, Knight RA, Hodson ME. Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet 1990;336:1081-1084.
21. Hudson I, Phelan PD. Are sex, age at diagnosis, or mode of presentation prognostic factors for cystic fibrosis? Pediatr Pulmonol 1987;3:288-297.
22. Wang SS, Fitz-Simmons SC, O'Leary LA, Rock MJ, Gwinn ML, Khoury MJ. Early diagnosis of cystic fibrosis in the newborn period and risk of Pseudomonas aeruginosa acquisition in the first years of life: a registry-based longitudinal study. Pediatrics 2001;107:274-279.
23. Renders NH, Sijmons MA, Van-Belkum A, Overbeek SE, Mouton JW, Verbrugh HA, et al. Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings. Res Microbiol 1997;148:447-454.
24. Thomassen MJ, Demko CA, Doershuk CF, Root JM. Pseudomonas aeruginosa isolates: comparisons of isolates from campers and from sibling pairs with cystic fibrosis. Pediatr Pulmonol 1985;1:40-45.
25. Aron Y, Polla BS, Bienvenu T, Dall'ava J, Dusser D, Hubert D. HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype. Am J Respir Crit Care Med 1999;159:1464-1468.
26. Jensen T, Lanng S, Faber M, Rosdahl VT, Hoiby N, Koch C. Clinical experiences with fusidic acid in cystic fibrosis patients. J Antimicrob Chemother [Suppl] 1990;B45-52.
27. Goerke C, Kraning K, Stren M, Doring G, Botzenhart K, Wolz C. Molecular epidemiology of community-acquired Staphylococcus aureus in families with and without cystic fibrosis patients. J Infect Dis 2000;181:984-989.
28. Givney R, Vickery A, Holliday A, Pegler M, Benn R. Methicillin resistant Staphylococcus in a cystic fibrosis unit. J Hosp Infect 1997;35:27-36.